Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. GSK’s Zejula meets primary goal in Phase III ovarian cancer trial
  2. Find out how pharma is fighting respiratory illnesses in the latest Pharma Technology Focus

Latest Content

Immunomedics stops Phase III breast cancer study early

Biopharmaceutical company Immunomedics has stopped the confirmatory Phase III ASCENT clinical trial of sacituzumab govitecan early after obtaining encouraging efficacy data in metastatic triple-negative breast cancer (mTNBC) patients.

Latest News


Go Top